SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Africa and its Issues- Why Have We Ignored Africa?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: TimF2/22/2006 12:01:56 PM
  Read Replies (1) of 1267
 
Resistance risk to malaria cure

The most effective cure for malaria could be lost unless new prescribing guidelines are followed, the World Health Organization (WHO) has warned.

Drug firms are being urged to stop selling artemisinin on its own to prevent the parasite building up resistance to the drug.

Artemisinin has a 95% malaria cure rate, but only if used in combination with certain other drugs, the WHO says.

If the drug became ineffective, another cure could be 10 years away, it added.

There are at least 300 million cases of the disease each year, resulting in about a million deaths annually.

Although there are several treatments for malaria, widespread resistance to conventional antimalarial drugs has contributed to higher death rates.

Dr Arata Kochi, director of the WHO's malaria department, said there had so far been no treatment failures due to resistance from the parasite which causes the disease.

But his team is watching the situation carefully, and concerns have been raised about decreased sensitivity to the artemisinin combination therapies (ACTs) in South-East Asia.

This is the region that has traditionally been the birthplace of anti-malarial drug resistance...

news.bbc.co.uk
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News